|Articles|February 25, 2022
Defining the Course & Navigating the Finish Line
Author(s)Zipher Medical Affairs CO., LLC
Trending on PharmExec
1
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
2
Pharma Roundup: Mounjaro Shows Advantages in Type 2 Diabetes, Immune System Linked to Long Covid Symptoms
3
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant
4
WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain
5